Table 1 Characteristics of the cohort (Volumes)

LVEDV (mL)

 Aortic Arch Anomaly

2

87.39

196.09

141.74

141.74

 Cardiomyopathy

8

82.55

179.02

114.37

93.66

 Coronary Artery Disease

9

21.43

123.24

79.72

89.55

 DORV

9

10.23

126.6

44.8

40.05

 Pulmonary Stenosis/Atresia

4

88.74

130.22

101.83

94.18

 TGA

9

39.18

167.03

113.35

133.77

 TOF

20

18.32

153.68

87.55

92.19

 Truncus arteriosus

3

70.23

201.44

124.13

100.73

 All

64

10.23

201.44

91.72

89.41

LVESV (mL)

 Aortic Arch Anomaly

2

22.06

68.3

45.18

45.18

 Cardiomyopathy

8

15.07

80.2

41.1

32.5

 Coronary Artery Disease

9

8.28

58.6

28.99

29.76

 DORV

9

4.18

43.33

17.4

17.7

 Pulmonary Stenosis/Atresia

4

31.56

53.28

38.25

34.09

 TGA

9

15.94

68.86

45.62

46.71

 TOF

20

5.95

69.01

34.21

33.22

 Truncus arteriosus

3

27.88

90.48

55.28

47.47

 All

64

4.18

90.48

35.16

31.66

RVEDV (mL)

 Aortic Arch Anomaly

2

100.34

215.08

157.71

157.71

 Cardiomyopathy

8

78.94

180.94

121.31

114.3

 Coronary Artery Disease

9

20.13

171.28

92.35

106.01

 DORV

9

25.31

236.22

80.0

69.72

 Pulmonary Stenosis/Atresia

4

126.2

264.54

176.92

158.48

 TGA

9

42.58

179.98

121.33

138.93

 TOF

20

28.63

265.7

137.12

129.67

 Truncus arteriosus

3

99.15

201.42

147.0

140.43

 All

64

20.13

265.7

122.19

115.43

RVESV (mL)

 Aortic Arch Anomaly

2

38.43

101.04

69.73

69.73

 Cardiomyopathy

8

13.27

86.81

45.25

36.43

 Coronary Artery Disease

9

8.49

70.26

34.04

33.57

 DORV

9

6.37

112.31

35.91

34.51

 Pulmonary Stenosis/Atresia

4

49.04

129.65

80.72

72.09

 TGA

9

15.93

84.68

50.08

41.52

 TOF

20

13.56

136.99

63.74

59.21

 Truncus arteriosus

3

43.3

73.47

56.37

52.34

 All

64

6.37

136.99

52.32

46.07